V116 (PCV21) was more cost-effective than PCV20 alone and PCV15 plus PPSV23 for the prevention of adult pneumococcal disease.

The Centers for Disease Control and Prevention (CDC) now recommends that American adults over the age of 50 receive the ...

Vaxcyte's robust financial position supports its strategic flexibility and extended timelines. Read more to see why I rate ...

Pfizer’s latest-generation pneumococcal conjugate vaccine is in line to reach more people in Latin America and the Caribbean ...

Togolese authorities confirmed over the weekend a resurgence of new meningitis cases in the Dankpen district, located in the ...

Short-term apnea is more common among hospitalized preterm infants who receive their 2-month vaccines compared with those who ...

The Pan American Health Organisation says Caribbean countries will have access to the 20-valent pneumococcal conjugate vacci ...

Pneumococcal Vaccine market Forecast to Surge to US$ 14.43 Billion by 2032, Achieving a Remarkable 6.4% CAGR ...

Pneumococcal vaccination reduces the risk of bacterial meningitis following cochlear implantation, as reported by a recent ...

Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines ...